Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and beta-lactams

garenoxacin has been researched along with beta-lactams in 3 studies

Compound Research Comparison

Studies
(garenoxacin)		Trials
(garenoxacin)		Recent Studies (post-2010)
(garenoxacin)		Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010) (beta-lactams)
19519467,5791793,395

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L1
Andriole, VT; Bassetti, M; Callan, DA; Dembry, LM; Farrel, PA1
Goldstein, EJ1

Other Studies

3 other study(ies) available for garenoxacin and beta-lactams

ArticleYear
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin

2001
Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Fluoroquinolones; Gram-Positive Bacteria; Humans; Indoles; Microbial Sensitivity Tests; Quinolones

2002
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002